Literature DB >> 51048

The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy.

D Schmidt.   

Abstract

Little is known about the influence of phenytoin and ethosuximide on primidone. Therefore we studied three groups of patients: 28 receiving primidone alone, 16 on comedication of primidone with phenytoin and 9 on primidone plus ethosuximide. Antiepileptic drug determinations were done with Kupferberg's gas chromatographic method. The results show that the addition of phenytoin--but not ethosuximide--does increase the plasma concentration of phenobarbital derived from primidone but not of primidone itself. The phenobarbital/primidone plasma concentration ratio is with 4.2 +/- 0.7 (+/- S.E.) significantly (P less than 0.001) higher in patients receiving primidone and phenytoin as compared to those on primidone alone (1.6 +/- 0.2) or together with ethosuximide (1.4 +/- 0.7). The effect of phenytoin occurs and persists for several days after the steady state plasma concentration of phenytoin has been reached. This effect is probably not due to induction of enzymes hydroxylating primidone but rather to inhibition of the metabolism and/or excretion of phenobarbital. A case of phenobarbital intoxication due to addition of phenytoin to primidone medication is described in detail.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51048     DOI: 10.1007/bf00314604

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  [Determination of phenytoin in saliva and its clinical significance].

Authors:  D Schmidt
Journal:  Bibl Psychiatr       Date:  1975

2.  Diphenylhydantoin concentrations in saliva.

Authors:  F Bochner; W D Hooper; J M Sutherland; M J Eadie; J H Tyrer
Journal:  Arch Neurol       Date:  1974-07

3.  The influence of diphenylhydantoin on primidone metabolism.

Authors:  R W Fincham; D D Schottelius; A L Sahs
Journal:  Arch Neurol       Date:  1974-03

4.  Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.

Authors:  B B Gallagher; I P Baumel; R H Mattson; S G Woodbury
Journal:  Neurology       Date:  1973-02       Impact factor: 9.910

5.  A clinical study of the effect of phenobarbital on diphenylhydantoin plasma levels.

Authors:  W D Diamond; R A Buchanan
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Sep-Oct

6.  The clinical significance of microsomal enzyme induction in the therapy of epileptic patients.

Authors:  E Sotaniemi; P Arvela; H Hakkarainen; E Huhti
Journal:  Ann Clin Res       Date:  1970-09

7.  Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.

Authors:  H J Kupferberg
Journal:  Clin Chim Acta       Date:  1970-08       Impact factor: 3.786

8.  The influence of phenobarbital on the half-life of diphenylhydantoin in man.

Authors:  M Kristensen; J M Hansen; L Skovsted
Journal:  Acta Med Scand       Date:  1969-04

9.  A clinical study of serum primidone levels.

Authors:  H E Booker; K Hosokowa; R D Burdette; B Darcey
Journal:  Epilepsia       Date:  1970-12       Impact factor: 5.864

10.  Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration.

Authors:  B B Gallagher; I P Baumel; R H Mattson
Journal:  Neurology       Date:  1972-11       Impact factor: 9.910

View more
  5 in total

1.  Effect of ethanol intake on phenytoin metabolism in volunteers.

Authors:  D Schmidt
Journal:  Experientia       Date:  1975-11-15

Review 2.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

Review 4.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient.

Authors:  M G Porro; H J Kupferberg; R J Porter; W H Theodore; M E Newmark
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.